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Abstract
Extracellular vesicles (EV) gained considerable interest in recent years as both diagnos‐
tic tools and templates for therapeutic applications. EVs carry a number of cell-specific 
markers which gave researchers the opportunity of employing them as liquid biopsies 
causing no discomfort to patients. On the other hand, they are very exciting candidates 
for drug delivery due to their eobiotic origin, physicochemical and size characteristics. 
Isolation of EVs is performed by several strategies, having advantages and disatvantages 
over each other. As such, the method of EV isolation and in particular exosome isola‐
tion determines the quality and purity of obtained vesicles. In this chapter, extracellular 
vesicle isolation methods are evaluated with regard to their further use. Methods such as 
ultracentrifugation with different modifications, size exclusion chromatography, ultra‐
filtration, affinity and precipitation are compared with respect to the yield efficacy and 
purity of isolates. Furthermore, the advantages and disadvantages of different methods 
according to the purpose of use are revealed. Recent progress and remaining challenges 
in the isolation of EVs with regard to diagnosis and treatment is reviewed and discussed. 
In order to select the most suitable method researchers should clearly define purity, yield, 
quantity and quality requirements for exosomes, and consider disadvantages of distinct 
isolation methods.
Keywords: exosomes, extracellular vesicles, ultracentrifugation, size exclusion 
chromatography, precipitation, ultrafiltration, affinity isolation
1. Introduction
Extracellular vesicles (EVs) are nano‐sized membrane vesicles, released by almost every cell 
types. EVs are shown to play crucial roles in many physiological events, as well as many path‐
ological processes. In the past decade, extensive research has been done using exosomes as 
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vehicles for diagnostic and therapeutic application. Previous studies showed that exosomes 
are promising systems for drug and nucleic acid delivery. Also, they might be promising 
tools for diagnosis. Different types of EVs, including exosomes, microvesicles and apoptotic 
bodies are released by cells. The vesicles are diverse and their quantity and quality depend 
on the type and origin of the cells. Among these, exosomes are the smallest vesicle type, with 
sizes ranging from 30 to 120 nm. They originate from multivesicular bodies (MVBs), the form 
of endosomes at a later stage of maturation. Exosomes are formed by inward budding of the 
endosomal membrane and accumulate in these MVBs. Later, these small vesicles in MVBs 
are released from the cells upon fusion of MVBs with the plasma membrane [1, 2]. In con‐
trast, microvesicles (MVs) are larger (50 nm–1 μm) and more heterogeneous in size. MVs are 
formed through direct outward budding of the plasma membrane. A heterogeneous popu‐
lation of vesicles (50 nm–5 μm) which are named apoptotic bodies are released during late 
stages of the programmed cell death. Each EV subtype contains different amounts of cargo 
molecules the identity of which is more or less similar among EV subtypes [3].
In different applications, it is important to make a clear distinction between MVs and exosomes 
because of the fact that they are different both in protein and genetic material content, and in 
size characteristics. This is important when post-purification processes such as protein char‐
acterization/isolation, RNA sequencing, targeted or conventional application in therapeutics 
delivery are to be investigated. This issue is still scarcely addressed and more research is needed 
in order to develop specific isolation methods for different EV subtypes. Also, there is still not 
enough knowledge about how the isolation methods affect physicochemical properties of exo‐
somes. As can be seen from their size distribution and similarities between their cargo mol‐
ecules, there is no strict border separating different EV subtypes. As the result, it is difficult to 
obtain highly purified exosome isolates that are completely devoid of other EV types. Given the 
fact that more and more research focuses on the potential of EVs for diagnostic and therapeutic 
application, the need of a reproducible method for their purification becomes more prominent.
Due to the complex nature of both intracellular matrix and extracellular environment from 
which EVs are isolated, not only the desired structures are attained. From biological fluids, 
contaminants such as proteins, lipoproteins and nucleic acids are also isolated together with 
the EVs [4–6]. Isolates from cell culture media are contaminated by supplements such as 
antibiotics and extraneous proteins and EVs coming from fetal bovine serum (FBS) [5, 7]. 
Prokaryotic contamination is also reported for body fluid EV preparations [8]. All of these 
contaminants affect the downstream applications of EVs.
In diagnostic applications, these contaminants could lead to false‐positive results and subse‐
quently erroneous interpretations. For example, free proteins can lead to over‐estimation of 
the protein cargo of EVs, and, if the protein concentration is considered for normalization of 
samples, this could lead to significant inconsistencies between results of different research 
groups.
In order to circumvent any potential interference with the therapeutic efficacy of the active 
compound, and to minimize the risk of unpredicted side effects, the composition simplic‐
ity of drug delivery systems is of utmost importance. Even though there are small number 
of ingredients in conventional nanoparticle‐based drug delivery systems (liposomes, solid 
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lipid nanoparticles, polymeric nanoparticles, etc.), there are still many debated aspects related 
to their safety. Considering their nature, EVs are obviously much more complicated than 
conventional nanoparticulate therapeutics. Therefore, in the therapeutic application field, 
impurities in EV isolates can be much more confusing. When EVs are isolated from cells 
designed to express a particular RNA molecule, other changes could also occur in the cellular 
machinery, and as a consequence, these could contribute to loading of unknown impurities 
into the EV lumen, leading to false‐positive results or even toxicity [9]. This problem can be 
accomplished, at least in part, by optimizing the isolation protocols, applying extra purifica‐
tion steps and by investigation of sensitive detection techniques for biomolecules [10–14]. 
However, currently, there is still not single method which ensures EV isolation fully devoid of 
impurities. In this respect, different isolation methods will be discussed for their applicability 
in isolation of exosomes intended either for diagnostic or therapeutic purposes.
2. Isolation methods and their convenience in different applications
EVs can be isolated from different types of bodily fluids such as blood, urine and saliva. 
Depending on the source cell, EVs took part in different roles in the body ecosystem and they 
are able to overcome natural barriers as cellular membrane, blood‐brain barrier and escape the 
immune system, etc. [1]. Moreover, their immunologic and cytotoxic activities are very low. 
Despite EVs’ promise for diagnostic and therapeutic applications, effective and pure isolation is 
still a problem which should be overcome. Existing isolation methods cause difficulty in terms 
of purity and reproducibility [15]. Besides, in some applications, it is important to make a clear 
distinction between MVs and exosomes because of the fact that they are different both in protein 
and genetic material content, and in size characteristics. This is important when post-purification 
processes such as protein characterization/isolation, RNA sequencing, targeted or conventional 
application in therapeutics delivery are to be investigated, as each EV subtype contains differ‐
ent amounts of cargo molecules [3]. This issue is still scarcely addressed and more research is 
needed in order to develop specific isolation methods for different EV subtypes.
Based on the main principle employed in the isolation process, there are basically five EV 
isolation methods. These are (1) Centrifugation‐based methods, (2) Chromatography‐based 
isolation, (3) Precipitation-based isolation, (4) Filtration-based isolation and (5) Affinity-based 
isolation. Each of these methods can be applied either individually or in combination with oth‐
ers in order to achieve higher yield or purity. Table 1 summarizes the methods for EV isolation.
2.1. Centrifugation‐based EV isolation
Owing to their colloidal size, EVs tend to sediment only under high centrifugal forces. The 
classical method for EV isolation is differential ultracentrifugation, as used in early exosome 
studies [16]. While this isolation method is still the most widely used approach, often with 
modifications of the duration, conditions and the speed of centrifugation steps, several sub‐
techniques have since been developed. Two commonly used techniques based on centrifuga‐
tion are differential ultracentrifugation and density gradient ultracentrifugation.
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3. Differential ultracentrifugation
This method generally employs at least one step of low‐speed (2000 g) centrifugation. In this step, 
whole cells and cell debris such as apoptotic bodies are removed. A second step of centrifugation 
at higher g‐force (5000–10,000 g) ensures removal of large EV aggregates and protein aggregates. 
The supernatant is then subjected to 1–3 h ultracentrifugation (≥100,000 g) at 4°C. EVs and high-
density proteins are enriched at the bottom of the ultracentrifuge tube in form of a tiny, barely 
visible sediment. The supernatant containing small proteins, cell culture supplements, buffer 
ions etc. is carefully discarded and the pellet is washed by adding cold phosphate buffered saline 
(PBS) and dispersing by vigorous vortexing or pipetting. A second step of ultracentrifugation is 
Isolation method Principle Required instrumentation and 
consumables
• Differential centrifugation • Sedimentation under high centrifu‐
gal forces based on density and par‐
ticle size
General purpose centrifuge, 
ultracentrifuge, conical centrifuge 
tubes, ultracentrifuge tubes
• Density gradient ultracentrifugation • Separation of EVs and other non‐ve‐
sicular components based on their 
buoyant density in a density gradi‐
ent under high centrifugal forces
• Chromatography‐based isolation • Size exclusion chromatography or 
gel filtration chromatography. Sepa‐
ration is achieved due to penetration 
of smaller particles into the pores 
of a matrix material during elution 
through a column
Prefilled or custom made 
chromatography columns, matrix 
material
• Ultrafiltration • Separation of EV subtypes and pro‐
teins using membrane filters. Sepa‐
ration is based on the size of differ‐
ent particles
Ultrafiltration device equipped 
with peristaltic pump, 
ultrafiltration cartridges, 
centrifugal filtration cartridges
• Polymer‐based precipitation • Reduction of EVs’ aqueous solubility 
in the presence of PEG
General purpose centrifuge, 
conical centrifuge tubes
• Salt precipitation • Charge neutralization by adding salt 
solution followed by reduction of 
EV solubility in low pH
• Charge‐based precipitation • Enhanced precipitation of EVs by 
addition of protamine sulphate 
based on their negative surface 
charge
• Affinity purification (specific anti‐
bodies, lectins and heparin)
• Capturing different EVs owing to 
specific molecules present on their 
membranes
Antibody coated chromatography 
matrices, microfluidic devices
Table 1. Commonly used EV isolation methods.
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performed. The supernatant is discarded, and finally, washed EVs are collected in little amount 
of cold PBS. The general steps of differential ultracentrifugation method for EV isolation are 
presented in Figure 1.
Materials required for this isolation method are sterile conical centrifuge tubes, clean and ster‐
ile ultracentrifuge tubes, pipettes for handling the liquid material, PBS or other suitable buffer 
according to the downstream applications. Equipment for the procedure includes conventional 
benchtop centrifuge with cooling mode; ultracentrifuge capable of performing centrifugation 
at g-forces higher than 100,000 g; a laminar flow biosafety hood in order to provide aseptic 
working conditions, especially when EVs are going to be used as therapeutic delivery systems.
Figure 1. General steps followed during EV isolation by differential ultracentrifugation. In this method, the source of 
EVs is first cleared from cells and cell debris by performing two steps of centrifugation in a conventional benchtop 
centrifuge. Afterwards, the cleared supernatant is ultracentrifuged at >100,000× g for at least 1 h, washed with PBS, 
ultracentrifuged again, and finally, the EVs are collected from the ultracentifuge tubes.
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The limitations of this method are its time‐consuming protocol and possibility of aggrega‐
tions under high centrifugal forces [15]. Lamparski et al. performed a comprehensive study on 
the development of clinical grade, good manufacturing practice (GMP)-compliant method for 
exosome purification [17]. They compared differential ultracentrifugation, ultrafiltration-cush‐
ion ultracentrifugation methods. The method of differential centrifugation produced highly 
variable results for exosome yield. Ultrafiltration followed by cushion ultracentrifugation has 
given more stable exosome yield with higher recovery, and regulatory compliance [17].
Tauro et al. investigated ultracentrifugation, density gradient separation and immunoaffinity 
capture methods [18]. Exosomes were isolated from 500 μl cell culture supernatant and the 
yield of applied methods were analysed. In this set of experiments, ultracentrifugation has 
given the best yield (375 μg), followed by density gradient separation (150 μg) and immunoaf‐
finity capture (195 µg). The size uniformity of exosomes has been shown to alter according to 
the isolation method. In this study, the immunoprecipitation method has been considered the 
best for exosome capture, as it yielded exosomes that have greater homogeneity and higher 
exosome‐associated protein content [18].
4. Density gradient ultracentrifugation
In density gradient ultracentrifugation, almost the same steps are followed as in differential 
ultracentrifugation. Materials required for this isolation method are sterile conical centrifuge 
tubes, clean and sterile ultracentrifuge tubes, pipettes for handling the liquid material, sucrose 
or iodixanol for preparation of discontinuous gradient, PBS or other suitable buffer according 
to the downstream applications [19]. Equipments required for performing this procedure are 
the same as those described in differential ultracentrifugation method.
The EVs are first isolated by applying the differential centrifugation steps and the first ultra‐
centrifugation step, as described under the differential ultracentrifugation, or alternatively, 
the isolation medium is concentrated using centrifugal filters. Next, a discontinuous sucrose 
or iodixanol gradient is prepared in ultracentrifugation tubes. For this purpose, sucrose solu‐
tions of gradually decreasing concentration are overlaid atop of each other. Crude EV pellet or 
concentrated isolation medium is then resuspended in little amount of PBS or buffer of choice, 
loaded on the gradient liquid and ultracentrifuged for extended period of time in order to sepa‐
rate EVs based on their buoyant density in the discontinuous viscous fluid [14, 18, 20]. The 
general steps of density gradient ultracentrifugation method for EV isolation are presented in 
Figure 2.
The ultracentrifugation method remains the most widely used approach for EV isolation. 
Lack of technical information about the type and the diameter of the rotor used, the volume 
and viscosity of the sample all represent challenges for establishing a standardized ultracen‐
trifugation‐based method [21].
The limitation of density gradient ultracentrifugation is its even long‐lasting ultracentrifuga‐
tion step as compared to differential ultracentrifugation. Moreover, this method requires an 
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additional wash step in order to remove the density gradient‐forming agent. On the other 
hand, its primary advantage is that several layers can be drawn after density gradient ultra‐
centrifugation and each of these layers can be characterized in order to distinguish between 
different EV subtypes separated owing to their buoyant density.
4.1. Chromatography‐based EV isolation
Size exclusion chromatography (SEC), also known as gel filtration chromatography, employs 
size difference of exosomes, microvesicles, apoptotic bodies, proteins and other components 
present in biological materials. The source material for EV isolation is loaded on a column 
prefilled with a stationary phase such as Sepharose© and Sephacryl©. A mobile phase, usually 
phosphate buffered saline, is then allowed to pass through the column. While the mobile phase 
Figure 2. General steps followed during EV isolation by density gradient ultracentrifugation. This method is similar 
to differential ultracentrifugation to the first ultracentrifuge step. The collected EVs are then transferred on top of a 
gradient‐forming agent and ultracentrifuged for extended period of time. EVs are separated as individual layers owing 
to the differences in their buoyant density and particle size. Finally, EVs are collected and analysed.
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Figure 3. General steps followed during EV isolation by size exclusion chromatography. EV source is either directly 
loaded to the column, or first concentrated by a suitable method in order to increase the yield and then loaded to the 
column. Subsequently, the mobile phase is added and gravity‐driven elution is performed.
passes through the column, it draws EVs into the stationary phase. During this process, smaller 
molecules such as proteins and small vesicles—the exosomes interact with the pores of the sta‐
tionary phase, leading to relative deceleration of their movement speed as compared with that 
of larger structures. As the result, EV subtypes are separated from each other as individual pop‐
ulations. Generally, these particle populations are collected in small fractions and each fraction 
is then analysed in terms of particle size and specific markers. Suitable fractions are then pooled 
and used for further downstream applications. General steps followed during SEC purification 
of EVs are schematized in Figure 3. Equipments required for isolation of exosomes by SEC are 
a prefilled column and a mobile phase to perform the elution (usually PBS). Fractions are col‐
lected in microcentrifuge tubes for later analysis and downstream applications. Alternatively, 
the SEC columns can be custom‐designed for investigational purposes—a syringe with removed 
plunger, or a small-volume burette could perform well as an empty column to be filled with a 
suitable chromatography resin of researchers’ choice.
An efficient single step EV isolation based on chromatography is described by Böing et al. 
[12]. They used Sepharose CL‐2B to create a separate column for size exclusion chromatogra‐
phy. As compared to the ultracentrifugation method from the literature, having highly vary‐
ing EV yields (2–80 %), this method was superior with 43% stable recovery of EVs, and almost 
complete removal of contaminating proteins. Furthermore, the method takes as little time as 
less than 20 minutes to complete [12]. Disadvantages of this method are (1) the accessibility of 
the chromatography column to contamination, therefore aseptic working conditions should 
be ensured especially if the isolated EVs are intended for therapeutic use; (2) a large number 
of fractions should be collected and analysed in order to make sure complete separation of 
EV subtypes and contaminating proteins and (3) contrarily to the simplicity and time effec‐
tiveness of the separation protocol, post‐isolation analysis of each fraction may be quite time 
consuming.
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4.2. Filtration‐based EV isolation
Filtration-based isolation of EVs relies on separation of different EV subtypes from each other 
and from contaminating proteins due to their size. A series of filtrations is performed and cell 
debris, microvesicles, exosomes and free proteins are efficiently separated by this method. 
General steps of the filtration procedure can be seen in Figure 4. Required equipments for this 
method are: a peristaltic pump to circulate the EV suspension during the process, filtration 
cartridges in order to perform the separation, a sample chamber and a filtrate collection cham‐
ber. A proof-of-concept study describing the use of tangential flow filtration method for exo‐
some isolation is performed by Heinemann et al. [22]. Authors made clear distinction between 
exosome and other EVs vesicles and aimed to efficiently separate them. Vesicles with much 
greater poly-dispersity are obtained as compared with differential filtration method. It was 
concluded that this method produces exosomal preparations with very high purity [22]. This 
method may be considered superior to ultracentrifugation method especially in cases where 
specific features of only exosomal fraction of extracellular vesicles are to be investigated, or if 
only exosomal fraction is desired for use in therapeutic delivery studies.
4.3. Precipitation‐based EV isolation
A common and easy to handle way of isolating EVs is precipitation. In precipitation protocols, 
polymers such as polyethylene glycol (PEG) [7, 23, 24] or salt solutions such as sodium acetate 
[25] are used for isolation. In this method, the sample is first incubated with the precipitating 
agent. During incubation, the polymers reduce EVs’ solubility and lead to their precipitation. 
After precipitation is completed, the pellet is simply collected by low‐speed centrifugation. 
Later, it was observed that EV yield increases when the precipitation with polymer is per‐
formed in acidic pH [26]. Another approach may be precipitation of the solubilized proteins, 
leaving a supernatant enriched with extracellular vesicles. This method is called ‘Protein 
Organic Solvent Precipitation (abbreviated as PROSPR)’. Acetone chloroform and trichloro‐
acetic acid are used to precipitate proteins. After proteins are removed, EVs are concentrated 
by filtration or vacuum-dried for proteomic analysis [27]. More recently, charge‐based precipi‐
tation of EVs has been reported. Researchers hypothesized that negatively charged EVs could 
interact with positively charged protamine sulphate. It was shown that charge‐based precipita‐
tion in conjunction with polymer gives higher yield as compared with PEG-precipitation and 
Figure 4. General steps followed during EV isolation by filtration. In this method, the source of EVs is sequentially 
passed through filtration cartridges with narrowing pore size. In the first step, cells and cell debris are removed. In the 
second filtration cartridge, the membrane passes exosomes and proteins into the filtrate while retaining microvesicles. 
Finally, the filtrate is passed through a cartridge with smallest pore size which passes free proteins and retains exosomes.
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Figure 5. General steps followed during EV isolation by precipitation. One of the following methods of precipitation 
can be chosen by the researcher: protein organic solvent precipitation, polymer‐driven precipitation, salting out with 
electrolyte solution or ionic precipitation by using cationic protamine. After an incubation period, the precipitate is 
collected by low‐speed centrifugation.
ultracentrifugation [23]. General steps followed during EV isolation by precipitation methods 
are represented in Figure 5. A salting‐out procedure for exosome precipitation is proposed by 
Brownlee et al. [25]. This method employed addition of acetate ions to EV source followed by 
immediate precipitation of EVs due to charge neutralization. They compared the exosomes 
obtained with this method to these obtained by ultracentrifugation and showed that exosomes 
isolated by these methods are indistinguishable in respect to their size and shape character‐
istics. In precipitation methods, the necessary equipments are: suitable tubes for performing 
the precipitation, a precipitating agent of choice (polymers, electrolytes or organic solvents), 
buffers for performing the washes and a benchtop centrifuge to collect the formed precipitate.
4.4. Affinity‐based EV isolation
Perhaps the most promising method for specific exosome isolation is the affinity precipitation in 
which specific antibodies are used. The most commonly employed antibodies in this method are 
monoclonal antibodies against specific exosomal membrane proteins (CD63, CD81, CD82, CD9, 
EpCam and Rab5). These antibodies are used alone or in combination [2]. Practically, the antibod‐
ies could be fixed on different types of materials such as magnetic beads [19, 28] or microfluidic 
devices [29–31]. The isolation is based on the binding efficiency of specific antibody to the specific 
antigen protein present on the exosome membrane (e.g. CD63). Magnet‐based kits are commer‐
cially available for specific isolation of CD81, CD63, CD9 or EpCam-containing exosomes.
Using saccharide residues on the exosomal surface is also another approach in affinity methods 
[32]. This approach is easy to apply, however, due to the huge number of cells that contain 
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mannose on their surface, the specificity of this affinity method is weak. Another affinity-based 
method relies on heparin affinity of EV. Based on previous observations that heparin blocks 
entry of EVs to recipient cells, a group of researchers hypothesized that heparin can bind 
directly to heparin sulphate proteoglycans on EVs’ surface and can be used for their isolation 
[33]. Like in the case with saccharide affinity, the fact that many cell types contain heparin 
sulphate proteoglycans the specificity of this capturing method is weak too. Different steps 
needed in affinity-based approaches for EV isolation can be seen in Figure 6.
4.5. Commercial isolation kits
The increased research on exosomes for diagnostic and therapeutic applications has led to 
the development of commercially available isolation kits. Commercial kits for EV isolation 
involve precipitation of the proteins on the outer membrane of EVs along with contaminating 
proteins of non‐EV origin. So, it is very important to determine the contaminating proteins 
before using their quantity for normalization of further experiments. Commercial kits for 
AV isolation include column‐based isolation kits, immunocapture‐based isolation kits and 
precipitation‐based kits. Table 2 summarizes the commercially available exosome isolation 
kits. Each of these kits is designed for isolating extracellular vesicles for various post‐isolation 
applications, and can be found on the manufacturers’ product lists.
Figure 6. Main steps followed during different affinity-based EV isolation methods. Antibody affinity, lectin affinity or 
heparin affinity can be employed depending on specific properties of expected EVs. For antibody affinity, a concentrated 
source medium or EV isolate previously obtained by another method is combined and incubated with antibody coated 
beads or plates. Afterwards, the exosomes are washed and eluted. For lectin affinity isolation, a low-speed centrifugation 
is performed in order to eliminate intact cells and cell debris, and the medium is incubated in the presence of lectins. 
Then EVs, selectively bound to the lectins, are collected by centrifugation. For heparin affinity isolation, the EV source 
is combined with heparin‐coated agarose beads and incubated. Later, EVs are released by adding concentrated salt 
solution and eluted by centrifugation. Very promising alternative is the use of microfluidic devices pre-coated with 
antibodies. This method ensures very fast capturing of specific EV subtypes.
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When, the commercial ExoQuick exosome isolation kit was compared with classical ultracen‐
trifugation, ExoQuick revealed ca. 19 times higher protein quantity in the isolated exosomal 
dispersion and is proven simpler and faster [34]. Yet no further experiments are performed 
to clarify if all the protein yields are truly of exosomal origin. Optiprep density gradient was 
successfully used for separation of exosomes, microvesicles, free proteins, non‐exosome small 
vesicles and proteasome from the same cells [19].
5. Comparison of exosome isolation methods in diagnosis and treatment 
of cancer
Table 3 gives examples of studies on EV isolation methods and summarizes the major findings.
As previously mentioned, in order to be applicable for therapeutic purpose, EV product 
should have a clearly defined origin and well-characterized particles with homogeneous size 
distribution. Because different EV subtypes are generated by different biogenesis pathways 
and originate from distinct cellular parts, their molecular cargo differs significantly. Therefore, 
when EVs will be used for delivery of specific small RNA molecules generated in the donor 
cells, it is crucial to distinguish whether obtained EVs are microvesicles or exosomes. While 
for particular applications such as RNA delivery or drug delivery exosomes may be pref‐
erable, for other applications such as vaccination and surface antigen display microvesicles 
might be more relevant [40]. For diagnostic application, especially in proteomics analyses, free 
protein contaminants may lead to false‐positive results. In so far as diagnosis is performed on 
body fluid samples, attention should be paid to numerous contamination factors like viruses, 
serum/plasma components, bacteria etc. Suitable method or combination of methods should 
be selected in order to eliminate all these factors that would affect final results.
Researchers should first consider the downstream application and then decide which method 
to use according to their advantages and disadvantages. These features of the methods men‐
tioned in this chapter are summarized below.
Name of the commercial kit Manufacturer Principle
ExoCap™ exosome isolation kit JRS Life Sciences GmbH Co. İmmunocapture and magnetic 
separation
Exosome‐Human CD81/CD63/CD9/
EpCAM isolation kits
Life Technologies Inc. İmmunocapture and magnetic 
separation
Exo‐spin™ exosome purification kit Cell Guidance Systems Ltd. Sedimentation and column filtration
qEV Size Exclusion Column iZON Ltd. Size exclusion chromatography
Invitrogen total exosome isolation kit Life Technologies Inc. Sedimentation
ExoQuick™ and ExoQuick‐TC™ 
exosome isolation kits
System Biosciences Sedimentation
ME™ exosome isolation kit New England Peptide Sedimentation
miRCURY™ exosome isolation kit Exiquon Inc. Sedimentation
Table 2. Commercially available kits for extracellular vesicle isolation.
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Source of EVs Origin Isolation method(s) used Findings and outcomes
Cell culture media CD14+ 
monocyte‐
derived 
dendritic cells 
from healthy 
donors
• Ultrafiltra‐
tion  cushion 
ultracentrifugation
• Filtration  cen‐
trifugation  cushion 
ultracentrifugation
• Differential 
Centrifugation
Ultrafiltration followed by cushion 
ultracentrifugation has given a stable exosome 
yield with higher recovery, and regulatory 
compliance. The method of differential 
centrifugation produced highly variable results 
with less effective exosome yield [17]
Whole blood Healthy donors • Differential 
centrifugation
• ExoQuick 
(Precipitation)
Two methods are compared with regard to how 
they affect the miRNA profile of the isolated 
exosomes. Comparable results were reported. 
ExoQuick is not recommended for obtaining 
exosomes intended for further biochemical and 
immunological studies [35]
Cell culture media/
biological fluids
NS Differential 
centrifugation
Step‐by‐step description of the 
ultracentrifugation method is provided [36]
Cell culture media LIM1863 colon 
cancer cell line
• Ultracentrifugation
• Density gradient 
separation (OptiPrep)
• Immunoaffinity 
capture
The least yield was achieved by 
ultracentrifugation, followed by OptiPrep, 
and the best was achieved by immunoaffinity 
capture. Ultracentrifugation was the faster 
method with only 2 hours required to complete. 
The immunoaffinity has considered the best 
method [18]
Cell culture media U87 and 293T 
cancer cells and 
normal HUVE 
cells
• Heparin affinity 
separation
• Ultracentrifugation
• ExoQuick
Using the affinity of EVs for heparin, researchers 
succeeded to demonstrate a simple and effective 
method to isolate highly pure populations of 
EVs [33]
Cell culture media K1735P 
melanoma cell 
line
• Ultracentrifugation
• Salting‐out procedure
Simple and cost-effective ion neutralization in 
acetate buffer media is described. Increased 
protein yield is observed in comparison to 
ultracentrifugation [25]
Cell culture media Huh‐7 liver 
cancer cell line
• Ultracentrifugation
• ExoQuick 
(Precipitation)
ExoQuick revealed higher protein quantity 
in the isolated exosomal dispersion, and has 
been proven simpler and faster [34]. Yet, it still 
remains to be clarified if the proteins are not of 
extraneous origin
Cell culture media MDA231 breast 
cancer cell line
• Sequential filtration
• Differential 
ultracentrifugation
Vesicles with much greater poly‐dispersity are 
obtained with the sequential filtration method. 
Exosomal preparations with very high purity are 
obtained [22]
Body fluids Platelet 
concentrate
• Size exclusion 
chromatography
Efficient, single step, rapid and cost-effective EV 
isolation method is described [12]
Cell culture media D3 murine 
embryonic stem 
cell line
• Differential 
ultracentrifugation;
• Centrifugal extrusion 
of whole cells to 
produce exosome‐mi‐
metic vesicles
Based on the protein and RNA amount in 
obtained EVs whole cell‐extrusion method has 
given nearly 250 times higher vesicle yield than 
simple exosome isolation [37]. Also, similar 
results were obtained with in vitro delivery 
studies
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5.1. Centrifugation‐based methods
Advantages
• these methods are recognized as gold standard for isolation of extracellular vesicles
• as the most commonly used method, ultracentrifugation is acceptable for isolating EVs for 
many application purposes
• well‐established protocols and troubleshooting are available
• ultracentrifugation can be used in combination with other techniques in order to provide 
better resolution of microvesicles and exosomes
• differential ultracentrifugation is able to discriminate between exosomes, small non-exo‐
some vesicles and microvesicles owing to their different buoyant density
Disadvantages
• the yield of EVs is highly varying in different setups
• requirement for expensive instrumentation and consumables
Source of EVs Origin Isolation method(s) used Findings and outcomes
Cell culture media D3 murine 
embryonic stem 
cell line
• Differential 
centrifugation;
• Microfluidics-mediat‐
ed extrusion of whole 
cells to produce 
exosome‐mimetic 
vesicles
Researchers compared the two methods for 
production of cell‐derived vesicles but no 
comparison of the protein and vesicle yield 
vas made [38]. Similar results were observed 
with EVs isolated with both methods in in vitro 
delivery studies
Cell culture media BT‐474 breast 
cancer cell line
• Differential 
ultracentrifugation
• ExoSpin Exosome Pu‐
rification Kit
• Invitrogen Total Exo‐
some Purification Kit
• PureExo Exosome 
Isolation Kit
All four methods are considered non-specific 
for exosome isolation because of the presence of 
large particles [39]. 
Cell culture media Monocyte‐
derived 
dendritic cells, 
HEK293T, 
RPE‐1, HeLa‐
CIITA, MDA‐
MB‐231, SHIN, 
IGROV-1, 
OV2008
• Differential 
ultracentrifugation
• Optiprep/Io‐
dixanol gradient 
ultracentrifugation
• Sucrose gradient 
ultracentrifugation
• Immunoaffinity 
capture
Subtypes of EVs were isolated by combining 
different methods such as ultracentrifugation 
and iodixanol gradient. Subgroups of small non 
exosomal vesicles, not carrying the exosomal 
markers were described [19]
Table 3. Studies dealing with EV isolation and major findings thereof.
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• disposable consumables like ultracentrifuge tubes meaning
• information about the rotor type and geometry, applied g‐force, solution viscosity and 
salinity should all be considered in order to achieve reproducible results
• the procedure of ultracentrifugation is very time laborious and requires substantial amount 
of hands‐on work. The density gradient ultracentrifugation takes even more time with ex‐
tra purification steps from start to finish
• in differential ultracentrifugation, not only exosomes are being collected at the end of the 
isolation. Therefore, for both diagnostic and therapeutic applications, isolates should be 
purified from contaminating proteins and other EV subtypes in order to avoid
5.2. Size exclusion chromatography
Advantages
• exosomes are isolated in a single step
• short operation time
• efficient elimination of contaminating proteins
• efficient separation of EV subtypes (provided that the sample loading volume is not too 
large)
• high purity of EV isolates
• no extra compounds are added in order to perform the isolation
Disadvantages
• samples are collected as a large number of fractions
• need to characterize each fraction in order to ensure presence of EVs and proteins
• requirement for aseptic working conditions in order to prevent microbial contamination
• exosomes and small non‐exosome vesicles cannot be separated
• large sample loading volume may lead to inefficient separation
5.3. Filtration‐based isolation
Advantages
• effective separation of exosomes and microvesicles
• simple and short operation
• efficient elimination of contaminating proteins
• efficient separation of EV subtypes (exosomes and microvesicles)
• high purity of EV isolates
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• the method is able to handle large‐volume sample
• no extra compounds are added in order to perform the isolation
• suitable for development of microfluidic isolation setups
Disadvantages
• the method cannot be applied on small‐volume samples
• exosomes and small non‐exosome vesicles cannot be discriminated
• possibility of occlusion of membranes during operation
• membranes should be carefully regenerated or discarded after use
5.4. Precipitation‐based isolation
Advantages
• ability to precipitate virtually all EVs in the biological sample
• very high yield
• versatility to perform isolation in different precipitation protocols
• fast and easy application
• protein solvent precipitation method may enhance diagnostic strength of exosomes and 
ensure contaminant‐free isolates for therapeutic applications
Disadvantages
• need to remove the precipitating polymer or salt for downstream applications
• production of highly heterogeneous and protein‐contaminated EV mixture
• need for extra purification steps
5.5. Affinity‐based methods
Advantages
• provides specific isolation of individual EV subpopulations
• high‐purity EV production
• suitable for development of microfluidic isolation setups
Disadvantages
• requirement of specific antibodies and targeting ligands
• need of solid knowledge about EVs’ structure
• possibility of functionality loss after detachment from antibodies
• not suitable for high‐volume samples
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6. Conclusion
Exosomes are gaining continuously increasing interest in biological, medical and pharmaceu‐
tical research fields. Treatment and diagnosis of cancer are two particularly promising appli‐
cations of exosomes. Isolation methods for exosomes are being advanced with the time and 
new modifications to available methods are being introduced. According to the available liter‐
ature, there is still no method that is free of shortages. For both applications, scientists should 
consider carefully the advantages and disadvantages of available methods. It is obvious from 
published methods that immunoaffinity isolation promises specific capture of exosomes from 
biological fluids, taking advantage of their membrane structures. Therefore, in cases where 
exosomes will be subject of investigation for diagnosis of cancer, immunoaffinity may pro‐
vide isolation of exosomes in the most sensitive and specific manner among all methods. By 
hyphenation of affinity methods to microfluidics field, even faster isolation, detection and 
analysis of exosomes can be achieved. The question of ‘which method is the best?’ currently 
remains unanswered for therapeutic applications of exosomes. Regulatory requirements for a 
standardized clinical grade exosome isolation method are yet to be established. Nevertheless, 
size exclusion chromatography and ultrafiltration methods which do not require incorpora‐
tion of extra compounds to facilitate the isolation provide exosome isolates with high purity. 
For cancer therapy, these two methods may be considered optimal.
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